Imaging Endpoints specializes in developing and deploying optimal imaging in early-stage trials, advancing imaging analysis into late-stage trials, and supporting regulatory submissions.

Imaging Endpoints

Canon Medical Systems Corporation is involved in medical imaging and healthcare IT solutions, offering products such as CT, MRI, ultrasound, and X-ray systems along with related support services. Self-described as providing comprehensive medical systems.

Canon Medical Systems Corporation

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Elihu Thomson

Thomas Edison

GE HealthCare Technologies Inc.

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Metric
Company Name	Imaging Endpoints	Canon Medical Systems Corporation	GE HealthCare Technologies Inc.	Siemens Healthineers AG
Symbol			GEHC	SHL
MSH ID	COM:IMAGINGENDPOINTS	CANON:MEDICAL:GLOBAL	COM:GEHEALTHCARE	COM:SIEMENS-HEALTHINEERS
Market	PRIVATE	PRIVATE	STOCKS	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare
Industry	Medical Imaging	Medical Devices	Medical - Healthcare Information Services	Medical - Devices
Country	US	JP	US	DE
Stage
Employee Count			51K	71K
Website	imagingendpoints.com	global.medical.canon	gehealthcare.com	siemens-healthineers.com
LinkedIn			gehealthcare
Founders

Metric
Market Cap	36.12B	63.81B
Enterprise Value
Monthly Web Traffic	1.37M	1.01M
Web Traffic Growth	0.23	-0.14
Valuation
Raised Capital	1.17B	2.50M

Metric
Revenue	19.55B	23.62B
Revenue (LTM)
Revenue (NTM)
Gross Profit	7.92B	8.94B
EBITDA	2.44B	4.46B
Operating Income	2.44B	3.03B
Net Income	3.10B	2.05B
EPS	6.82	1.84
Diluted EPS	6.78	1.84
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.41	0.38
Operating Profit Margin	0.13	0.13
EBITDA Margin	0.12	0.19
Net Profit Margin	0.08	0.08
Return on Equity	0.22	0.10
Return on Assets	0.05	0.04
Return on Capital Employed	0.11	0.08

COM:IMAGINGENDPOINTS

Imaging Endpoints

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	19.27	38.55
P/B Ratio	4.68	3.22
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.15	2.83
EV Multiple	10.08	16.20

Metric
Days Sales Outstanding	84.00	136.10
Days Payables Outstanding	87.39	57.55
Days Inventory Outstanding	64.08	125.45
Operating Cycle	141.20	232.75
Cash Conversion Cycle	51.81	179.79
Asset Turnover	0.61	0.48

Metric
Operating Cash Flow	2.10B	2.61B
Free Cash Flow	1.71B	1.87B
Cash Flow to Debt	0.23	3.53
Operating Cash Flow/Sales	0.11	0.11
Free Cash Flow Yield	0.05	0.02

Metric
Cash & Equivalents	2.50B	2.83B
Accounts Receivable	-185M	-445.73M
Inventory	1.96B	4.41B
Goodwill	12.94B	18.66B
Debt to Capitalization	0.58	0.47
Debt to Assets	0.32	0.01
Current Ratio	1.25	1.05
Quick Ratio	0.83	0.89

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	-0.02
R&D to Revenue	0.06	0.09
SG&A to Revenue		0.17